Ohr Pharmaceutical Inc Business Finance Contracts & Agreements

63 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Subscription and Investment Representation Agreement, dated May 29, 2024
Investment Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2024
Redemption and Termination Agreement, dated January 26, 2024, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2024
Exchange Agreement, dated October 17, 2023, by and between NeuBase Therapeutics, Inc. and the Warrant Holder thereto
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2023
Form of Series A-1 Common Stock Purchase Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2023
Registration Rights Agreement, dated June 28, 2023
Registration Rights Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Securities Purchase Agreement, dated June 28, 2023 (PIPE Private Placement)
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2023
Securities Purchase Agreement, dated June 28, 2023 (Registered Direct Offering)
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2023
Form of Placement Agent Common Stock Purchase Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Form of Pre-Funded Common Stock Purchase Warrant (PIPE Private Placement)
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Form of Pre-Funded Common Stock Purchase Warrant (Registered Direct Offering)
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Form of Series B Common Stock Purchase Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Form of Series A Common Stock Purchase Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2023
Purchase Agreement, dated December 28, 2022, by and between NeuBase Therapeutics, Inc. and Alumni Capital LP
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2022
Underwriting Agreement, dated as of April 22, 2021, by and among NeuBase Therapeutics, Inc. and RBC Capital Markets, LLC, Oppenheimer & Co. Inc. and Chardan Capital Markets LLC,...
Underwriting Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2021
Underwriting Agreement, dated as of April 28, 2020, by and between NeuBase Therapeutics, Inc. and Oppenheimer & Co. Inc. and BTIG, LLC, as representatives of the underwriters...
Underwriting Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2020
Registration Rights Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signature pages thereto
Registration Rights Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Common Stock Purchase Agreement, dated as of July 12, 2019, between the Company and the purchasers named in the signatures pages thereto
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Amendment to Restricted Stock Purchase Agreement, made as of December 26, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Restricted Stock Purchase Agreement, made as of September 6, 2018, by and between NeuBase Therapeutics, Inc. and Dietrich A. Stephan
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Form of NeuBase Therapeutics, Inc. Convertible Promissory Note
Note Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Form of NeuBase Therapeutics, Inc. Note Purchase Agreement
Note Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2019
Form of NeuBase Therapeutics, Inc. Warrant Certificate
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
PA
2019
Form of Restricted Stock Agreement
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2017
Form of Stock Option Agreement
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
DE
2017
Securities Purchase Agreement dated as of April 5, 2017, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2017
Form of Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2017
Form of Securities Purchase Agreement
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2017
Form of Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2017
Securities Purchase Agreement, dated December 7, 2016, by and among Ohr Pharmaceutical, Inc. and the purchasers listed therein
Purchase Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2016
Form of Series B Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2016
Form of Series A Warrant
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2016
Restricted Stock Agreement, dated December 11, 2015, between Ohr Pharmaceutical, Inc. and Irach B. Taraporewala
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2015
Form of Stock Option
Stock Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2015
Underwriting Agreement, dated February 6, 2015, by and between Ohr Pharmaceutical, Inc. and Cowen and Company, LLC, as representative of the Underwriters named therein
Underwriting Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2015
Amendment No. 1 to Warrant Agreement, dated January 15, 2015
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2015
Assignment and Assumption Agreement between Ohr Pharmaceutical, Inc. and Ohr Holdco, Inc., dated May 30, 2014
Assignment Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2014
Contribution Agreement
Contribution Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2014
Form of Subscription Agreement, dated April 8, 2014, by and among Ohr Pharmaceutical, Inc. and each of the investors
Subscription Agreements
Ohr Pharmaceutical Inc
Biotechnology
NY
2014
Amendment No. 1 to Warrant Agreement, dated March 11, 2014
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2014
Amendment 3 to Warrant Agreement, Dated April 18, 2013
Warrant Agreements
Ohr Pharmaceutical Inc
Biotechnology
2013